Trials / Enrolling By Invitation
Enrolling By InvitationNCT02471170
Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect blood samples to detect potential markers of pancreatic cancer in the blood and link these findings to medical and health information. Information from this study may help to provide insight into the detection of pancreas cancer in the blood before it can be found by other methods or provide a method of monitoring the status of pancreatic cancer throughout a treatment course. Another purpose of this study is to collect blood to create a biobank.
Conditions
Timeline
- Start date
- 2015-09-10
- Primary completion
- 2035-01-01
- Completion
- 2035-01-01
- First posted
- 2015-06-15
- Last updated
- 2025-04-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02471170. Inclusion in this directory is not an endorsement.